An analysis of 138 ovarian tissue specimens revealed that the co-expression of CD44 and myeloid differentiation factor 88 (MYD88) in patients with epithelial ovarian carcinoma correlated with tumour progression, metastasis, and recurrence [165]. Here, CD44 is linked to neoplasm.